{
    "2019-12-13": [
        [
            {
                "time": "2023-10-05",
                "original_text": "FDA approves Sarepta's muscular dystrophy drug",
                "features": {
                    "keywords": [
                        "FDA",
                        "approves",
                        "Sarepta",
                        "muscular dystrophy",
                        "drug"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Investor Interest Rising in “QUAL” ETF as Fund Sees Higher Inflows",
                "features": {
                    "keywords": [
                        "Investor Interest",
                        "Rising",
                        "QUAL ETF",
                        "Higher Inflows"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance",
                        "ETFs"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}